Form D Explorer

Inspect source fieldsReport a record issue

Form D — Rhinal Therapeutics Inc.

0002080382-25-000001 · filed Aug 7, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$1,000,000
Reported amount sold
$20,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Rhinal Therapeutics Inc.
CIK
2080382
Entity
Corporation
Jurisdiction
NEVADA
Year incorporated
2023
Address
732 S 6TH ST
LAS VEGAS, Nevada 89101
Phone
7029816980

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗